Tag: Prescription Drugs
Approved-Label Populations for New Drugs Broader Than Trial Populations
Inconsistency seen most often in terms of patient fitness, with variance in almost all approved indications
Kerendia Approved for Heart Failure With Left Ventricular Ejection Fraction ≥40 Percent
Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart failure
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
Further increase in risk was seen with prescription frequency, with higher risk for 12 or more prescriptions
Hypercholesterolemia Treatment Falls Short of Guidelines
In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines
Preschool Depression Intervention Has Long-Term Beneficial Effects
Those with remission at preadolescence have lower lifetime use of antipsychotics and intensive mental health interventions
NRTI Use Linked to Risk for Primary Open-Angle Glaucoma
Increased risk seen in adjusted analyses in association with nucleoside and nucleotide reverse transcriptase inhibitor use
Suspected Pharmacologic Triggers Do Not Appear to Cause Microscopic Colitis
No evidence of causal relationship seen between previously suspected medications and risk for microscopic colitis
Review Compares Efficacy, Safety of Treatments for Hidradenitis Suppurativa
Differences between adalimumab and other targeted treatments mainly not significant
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants
ADHD Medications Remain Linked to Lower Risk for Real-World Adverse Outcomes
Magnitude of these associations decreases alongside increasing prescription rates
